The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of function-Reference-Cited by-同舟云学术

The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of function

Published:2010-10-14 Issue:12 Volume:24 Page:2005-2013
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Kox C,Zimmermann M,Stanulla M,Leible S,Schrappe M,Ludwig W-D,Koehler R,Tolle G,Bandapalli O R,Breit S,Muckenthaler M U,Kulozik A E

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010203.pdf

Reference48 articles.

1. Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM . Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program 2004, 118–145.

2. Herold R, von Stackelberg A, Hartmann R, Eisenreich B, Henze G . Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference. J Clin Oncol 2004; 22: 569–570.

3. Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V et al. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr 1987; 199: 151–160.

4. Yokota S, Hansen-Hagge TE, Ludwig WD, Reiter A, Raghavachar A, Kleihauer E et al. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 77: 331–339.

5. Flohr T, Schrauder A, Cazzaniga G, Panzer-Grumayer R, van der Velden V, Fischer S et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 771–782.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China;Annals of Hematology;2024-04-06

2. Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia;Oncohematology;2024-04-02

3. Diagnostic and therapeutic approaches for lymphoblastic lymphomas from progenitor cells in children and adolescents;Oncohematology;2023-12-08

4. How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults;Blood;2023-04-05

5. Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia;Cancer;2022-11-12